Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury

Health Canada reviewed the potential risk of liver injury with Pradaxa after receiving reports of severe liver injury from the manufacturer. The manufacturer was asked to provide all available data on Pradaxa and the risk of liver injury.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2024-05-10

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data